LYFE to Lead in Healthcare Play
30 Aug 2024
US$ 19.00
LYFE Capital is taking a leading role in the issuance of US$200 million US dollar-denominated European convertible...
Related Publications
KKR & Co Inc (KKR) has sold its 22.2% stake in PT Nippon Indosari Corpindo Tbk, the operator of Sari Tori, and ......
MARS Growth Capital (MARS) and HSBC Holdings Plc (HSBC) have led a US$150 m refinancing for Eruditus Executive ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.